comparemela.com

Latest Breaking News On - Brains senior management - Page 1 : comparemela.com

Brains Bioceutical Corp Enters USD $490 Billion USA Pharmaceutical Market by way of DMF from US FDA

Brains Bioceutical Corp Enters USD $490 Billion USA Pharmaceutical Market by way of DMF from US FDA
newjerseytelegraph.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from newjerseytelegraph.com Daily Mail and Mail on Sunday newspapers.

Brains Bioceutical Corp Enters USD $490 Billion USA Pharmaceutical Market by way of DMF from US FDA

Brains Bioceutical Corp Enters USD $490 Billion USA Pharmaceutical Market by way of DMF from US FDA
pittsburghstar.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pittsburghstar.com Daily Mail and Mail on Sunday newspapers.

Brains Bioceutical Corp Enters USD $490 Billion USA Pharmaceutical Market by way of DMF from US FDA

Brains Bioceutical Corp Enters USD $490 Billion USA Pharmaceutical Market by way of DMF from US FDA
saltlakecitysun.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from saltlakecitysun.com Daily Mail and Mail on Sunday newspapers.

Brains Bioceutical Corp : Brains Bioceutical Corp Successfully Obtains Home Office Schedule 1 Controlled Drug License

Brains Bioceutical Corp.: Brains Bioceutical Corp Successfully Obtains Home Office Schedule 1 Controlled Drug License Brains Bioceutical Corp., One of the rare few EU-GMP Certified CBD API producers in the UK awarded a Schedule 1 Controlled Drug Licence by the UK Home Office, maintaining our industry leading advantage for Cannabinoid based medicines VANCOUVER, BC / ACCESSWIRE / December 17, 2020 / Brains Bioceutical Corp. ( Brains ) a global leader and manufacturer of pharmaceutical, wellness and veterinary cannabidiol (CBD) Active Pharmaceutical Ingredient (API), is proud to announce its landmark accomplishment of being granted a Schedule 1 Controlled Drug License, which is inclusive of THC, from the United Kingdom Home Office. Concurrently, Brains has begun initial development of its new additional facility for CBD API production and R&D activities associated with other cannabinoids.

Brains Bioceutical Corp Successfully Obtains Home Office Schedule 1 Controlled Drug License

Brains Bioceutical Corp Successfully Obtains Home Office Schedule 1 Controlled Drug License
albuquerqueexpress.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from albuquerqueexpress.com Daily Mail and Mail on Sunday newspapers.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.